Publications by authors named "T Bergerova"
Article Synopsis
- The study aimed to gather data on the molecular epidemiology and antibiotic resistance of MRSA in the Czech Republic through the collection and analysis of 441 MRSA isolates from 11 hospitals.
- Results showed that 81.41% of MRSA isolates belonged to the CC5-MRSA clone, with a high prevalence of SCCmec type II, primarily affecting older inpatients and linked to healthcare settings, alongside notable resistance to multiple antibiotics.
- The findings highlighted the dominance of the CC5-MRSA-II lineage, including the emerging t586 strain, and emphasized the necessity for continued MRSA surveillance to keep track of shifts in its epidemiology.
The aim of the present study was to characterize sporadic cases and an outbreak of NDM-like-producing recovered from hospital settings, in Czechia. During 2016, 18 isolates including 10 complex (9 and 1 ), 4 , 1 , 1 , 1 , and 1 that produced NDM-like carbapenemases were isolated from 15 patients. Three of the patients were colonized or infected by two different NDM-like producers.
View Article and Find Full Text PDFMatrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) -based identification of bacteria and fungi significantly changed the diagnostic process in clinical microbiology. We describe here a novel technique for bacterial and yeast deposition on MALDI target using an automated workflow resulting in an increase of the microbes' score of MALDI identification. We also provide a comparison of four different sample preparation methods.
View Article and Find Full Text PDFThe aim of this study was to characterize the first cases and outbreaks of OXA-48-like-producing Enterobacteriaceae recovered from hospital settings in the Czech Republic. From 2013 to 2015, 22 Klebsiella pneumoniae isolates, 3 Escherichia coli isolates, and 1 Enterobacter cloacae isolate producing OXA-48-like carbapenemases were isolated from 20 patients. Four of the patients were colonized or infected by two or three different OXA-48-like producers.
View Article and Find Full Text PDFCell therapy products represent a new trend of treatment in the field of immunotherapy and regenerative medicine. Their biological nature and multistep preparation procedure require the application of complex release criteria and quality control. Microbial contamination of cell therapy products is a potential source of morbidity in recipients.
View Article and Find Full Text PDF